Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable ...
With investors rushing to secure Venture Capital Trust (VCT) allocations ahead of the expected reduction in the 30% income tax relief, ...
As the 2025/26 tax year draws to a close, many clients will already have acted on year-end planning opportunities. But with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results